# A Clinical Study to Evaluate SM17 in Healthy Participants

> **NCT07466940** · PHASE1 · COMPLETED · sponsor: **SinoMab BioScience Ltd** · enrollment: 30 (actual)

## Conditions studied

- Atopic Dermatitis
- Asthma
- Inflammatory Bowel Disease

## Interventions

- **BIOLOGICAL:** SM17
- **DRUG:** SM17 placebo

## Key facts

- **NCT ID:** NCT07466940
- **Lead sponsor:** SinoMab BioScience Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-14
- **Primary completion:** 2026-02-03
- **Final completion:** 2026-02-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07466940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07466940, "A Clinical Study to Evaluate SM17 in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07466940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*